Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
50 participants
INTERVENTIONAL
2019-11-27
2021-09-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Efficacy of Lumbar Plexus Bloc After Hip Surgery
NCT00150865
Erector Spinae Block vs Conventional Analgesia for Postoperative Analgesia in PCNL
NCT06935006
Ultrasound-guided Lumbar Erector Spinae Plane Block in Patients Undergoing Lower Limb Vascular Surgery
NCT04644562
Efficacy of an Erector Spinae Plane Block in VATS/RATS
NCT04400721
Perioperative Local Anesthesia Block in Spine Surgery
NCT05094427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treated
active treatment (Local anaesthetic): Local administration of ropivacaine 30 mL (5mg/mL)
Local administration of ropivacaine
Erector nerve block with local ropivacaine injection in addition with conventional anesthesia for spine surgery
Control
Local administration of Placebo ( Saline Solution)
Local administration of placebo (saline solution)
injection of saline solution in addition with conventional anesthesia for spine surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Local administration of ropivacaine
Erector nerve block with local ropivacaine injection in addition with conventional anesthesia for spine surgery
Local administration of placebo (saline solution)
injection of saline solution in addition with conventional anesthesia for spine surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* lumbar spine surgery (2-4 levels)
* posterior approach
* ASA 1-3
Exclusion Criteria
* age \< 18yrs
* \<50 kg and \>120 kg
* pregnant
* renal or hepatic severe desease
* ASA 4
* no French speaking
* emergency surgery
* local or systemic infection
* surgical resumption of the surgical site
* surgery involving a thoracic approach
* allergy to local anesthetics
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Nimes
Nîmes, Gard, France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Avis G, Gricourt Y, Vialatte PB, Meunier V, Perin M, Simon N, Claret PG, El Fertit H, Lefrant JY, Bertrand M, Cuvillon P. Analgesic efficacy of erector spinae plane blocks for lumbar spine surgery: a randomized double-blind controlled clinical trial. Reg Anesth Pain Med. 2022 Jul 21:rapm-2022-103737. doi: 10.1136/rapm-2022-103737. Online ahead of print.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-001678-26
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
LOCAL/2018/PC-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.